医疗索赔识别心肌梗死后心血管与出血事件的准确性:TRANSLATE-ACS研究二次分析
索赔识别的累积发生率均低于医生裁定,心梗和卒中的一致性仅为中等,出血事件一致性差。结论提示医疗索赔诊断准确性有限,心血管研究中需替代方法确保安全性监测。
要点
- 医疗索赔识别的1年心梗、卒中、出血累积发生率均低于医生裁定。
- 索赔与裁定心梗一致性中等(κ=0.76),卒中中等(κ=0.55)。
- 索赔与裁定出血事件一致性差(κ=0.24),中重度出血更差(κ=0.15)。
核心结论
- 医疗索赔识别的1年心梗、卒中和出血事件率均低于医生裁定。
- 索赔诊断识别心梗和卒中入院仅中等准确,出血事件准确性有限。
- 心血管研究可能需要替代方法以确保良好的安全性监测。
研究设计与样本
- 收集233家美国医院1年内所有再住院的医疗索赔表格和记录。
- 事件由研究医生根据预设标准独立裁定,索赔事件按ICD-9-CM诊断和操作代码识别。
- 采用κ统计量评估索赔识别事件与医生裁定事件之间的一致性。
主要发现
- 医疗索赔识别的1年累积发生率:心梗4.3%,卒中0.9%,出血5.0%。
- 医生裁定的1年累积发生率:心梗4.7%,卒中0.9%,出血5.4%。
- 索赔与裁定心梗一致性κ=0.76(95%CI 0.73-0.79),卒中κ=0.55(95%CI 0.41-0.68)。
- 任何住院出血事件一致性κ=0.24(95%CI 0.19-0.30),GUSTO中重度出血κ=0.15(95%CI 0.11-0.20)。
关键数值与推荐
- 复发心梗和卒中采用预设标准裁定,出血采用GUSTO量表定义。
- 医疗索赔基于Uniform Bill-04索赔表格,使用ICD-9-CM诊断和操作代码识别事件。
临床怎么用
- 医疗索赔数据识别心梗后事件可能低估事件率,心梗和卒中准确性中等,出血准确性有限。
- 在心血管研究的安全性监测中,可能需要替代方法以确保事件识别的准确性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Pragmatic clinical trial designs have proposed the use of medical claims data to ascertain clinical events; however, the accuracy of billed diagnoses in identifying potential events is unclear. OBJECTIVES: To compare the 1-year cumulative incidences of events when events were identified by medical claims vs by physician adjudication and to assess the accuracy of bill-identified events using physician adjudication as the criterion standard. DESIGN, SETTING, AND PARTICIPANTS: This post hoc analysis of a clinical trial assessed the medical claims forms and records for all rehospitalizations at 233 US hospitals within 1 year of the index acute myocardial infarction (MI) of 12 365 patients enrolled in the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) study between April 1, 2010, and October 31, 2012. Fourteen patients (0.1%) died during the index hospitalization and were excluded from analysis. Recurrent MI, stroke, and bleeding events were identified per the International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis and procedural codes in medical bills. These events were independently adjudicated by study physicians through medical record reviews using the prespecified criteria of recurrent MI and stroke and the bleeding definition by the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) scale. Medical claims were reported on a Uniform Bill-04 claims form; claims were collected from all hospitals visited by patients enrolled in TRANSLATE-ACS. Agreement between medical claims-identified events and physician-adjudicated events over the 12 months after discharge was assessed with the κ statistic. Data were analyzed from January 30, 2015, to March 2, 2017. MAIN OUTCOMES AND MEASURES: Event rates within 1 year after MI. RESULTS: Among 12 365 patients with acute MI, 8890 (71.9%) were men and mean (SD) age was 60 (11.6) years. The cumulative 1-year incidence of events identified by medical claims was 4.3% for MI, 0.9% for stroke, and 5.0% for bleeding. Incidence rates based on physician adjudication were 4.7% for MI, 0.9% for stroke, and 5.4% for bleeding. Agreement between medical claims-identified and physician-adjudicated events was modest, with a κ of 0.76 (95% CI, 0.73 to 0.79) for MI and 0.55 (95% CI, 0.41 to 0.68) for stroke events. In contrast, agreement between medical claims-identified and physician-adjudicated bleeding events was poor, with a κ of 0.24 (95% CI, 0.19 to 0.30) for any hospitalized bleeding event and 0.15 (95% CI, 0.11 to 0.20) for moderate or severe bleeding on the GUSTO scale. CONCLUSIONS AND RELEVANCE: Event rates at 1 year after MI were lower for MI, stroke, and bleeding when medical claims were used to identify events than when adjudicated by physicians. Medical claims diagnoses were only modestly accurate in identifying MI and stroke admissions but had limited accuracy for bleeding events. An alternative approach may be needed to ensure good safety surveillance in cardiovascular studies. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01088503.
引用
- Guimarães PO, Krishnamoorthy A, Kaltenbach LA, et al. Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study. JAMA Cardiol. 2017. PMID: 28538984. doi:10.1001/jamacardio.2017.1460
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。